DailyIQ
Last updatedUpdating…

MTD·Mettler-Toledo International Inc.

$1533.07
-8.56 (-0.56%)
Pre-Market
High
$1,532.51
Open
$1,532.00
Market Cap
30.81B
52W High
$1,585.72
Low
$1,529.00
P. Close
$1,533.07
P/E
34.02
52W Low
$1,023.05
Fwd P/E
29.63
DailyIQ Est.
$1478.77
Inst. Ownership
45.6%
Short Interest
3.47%
Days to Cover
4.2
Technical Score (1D)
91
BULLISH
News Sentiment
58
BULLISH
On Oct 6, Barclays raised its price target for Mettler‑Toledo International to $1,700 from $1,575 while keeping an overweight rating. The upgrade reflected confidence in the company’s earnings outlook and product pipeline. Barclays noted that the new target represented a modest upside relative to the current market price, indicating a positive view of MTD’s near‑term prospects. The rating was maintained at overweight, underscoring the firm’s continued support for the stock. No other developments were reported for the day.
LOW TARGET
$1200 -21.5%
2 analysts
MEAN TARGET
$1458 -4.6%
12 analysts
HIGH TARGET
$1600 +4.6%
7 analysts
PRICE RANGE
$1200.00 - $1600.00
SB / B / H / S / SS
4/6/9/1/1
DAILYIQ EST.
$1478.77 (-3.3%)
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYQ
Country
United States
Website
Symbol
MTD
Description
Mettler-Toledo International Inc. is a global provider of precision instruments and related services, catering to diverse industries across the Americas, Europe, and Asia. The company's core business is built upon two primary segments: laboratory instruments and industrial instruments. Within its laboratory segment, Mettler-Toledo offers a comprehensive suite of analytical tools and software solutions, including balances, titrators, and laboratory data management systems. Its industrial segment provides weighing equipment, inspection systems, and software solutions for manufacturing, logistics, and retail applications. Serving a broad customer base that includes life science, food production, and chemical industries, Mettler-Toledo leverages a global sales and distribution network to deliver its offerings.
Bought (1Y)
0 shares
$0
Sold (1Y)
4,254 shares
$6.1M
SHUMAN-FABBRI NATALIA-
Award/Grant16 shares2026-08-28
Kaltenbach PatrickPresident and CEO
Option Exercise942 shares2026-08-27
Kaltenbach PatrickPresident and CEO
Sell942 shares2026-08-27
Kaltenbach PatrickPresident and CEO
Option Exercise942 shares2026-08-27
SALICE THOMAS P-
Option Exercise417 shares2026-08-05
64/ 100
Neutral / mixed
Overall: Neutral
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
59.4%
Net Margin
21.6%
Revenue CAGR
4.3%
Current Ratio
1.14x
Debt / Equity
-91.05x
Return on Equity
-3677.4%
Earnings Summary
Mettler‑Toledo International Inc. is a global provider of precision instruments and related services, operating through laboratory and industrial segments that serve life science, food production, and chemical industries. The company’s focus on high‑quality analytical tools places it firmly within the diagnostics and research sector of healthcare. In the most recent quarters, MTD delivered EPS that consistently beat estimates, with Q4 2024 EPS of $12.41 versus an estimate of $11.72 and Q1 2025 EPS of $8.19 versus $7.88; revenue also grew, reaching $1.029 billion in Q2 2025 from $883 million in Q1 2025, a 17.5% increase. The trend of EPS growth continued into Q3 2025, where EPS rose to $11.15 against an estimate of $10.66, while revenue climbed to $1.030 billion, a 4.5% rise from the prior quarter. Historically, MTD has shown a steady YoY revenue growth trajectory, with Q4 2025 revenue of $1.129 billion up 7.6% from the same period a year earlier, and EPS growth maintained a positive trend, often exceeding analyst expectations. The company’s earnings pattern reveals consistent profitability, with operating margins exceeding 29% in Q2 2025, underscoring its high‑quality, mission‑critical business model. Recent news highlights a Barclays upgrade on October 6, raising the price target to $1,700 from $1,575 while maintaining an overweight rating, reflecting confidence in MTD’s earnings outlook and product pipeline.

EPS

EstBeatMiss
$8.10$9.59$11.07$12.56$14.05Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$12.09 - -
Q2'26$10.81$11.46+6.1%
Q1'26$8.79$8.91+1.4%
Q4'25$12.93$13.36+3.3%
Q3'25$10.66$11.15+4.6%
Q2'25$9.60$10.09+5.1%

Revenue

EstBeatMiss
$920M$979M$1.0B$1.1B$1.2BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.1B - -
Q2'26$1.0B$1.0B-1.1%
Q1'26$951M$947M-0.4%
Q4'25$1.1B$1.1B+1.3%
Q3'25 - $1.0B -
Q2'25 - $983M -

Market Data

MTD Stock Snapshot

BULLISH91/100
$1531.10−$6.90 (0.4%)
Market cap
30.81B
P/E ratio
34.0
Day range
$1529.00 – $1532.51
News sentiment
58/100 · Neutral
Analyst target
$1458.08 (-4.8%)
Consensus
Hold · 21 analysts
52-week range+49.7% off low · -3.4% from high
$1023.05$1585.72
Price $1531.10 DailyIQ Est. $1478.77

MTD's technical picture is constructive, with trend and momentum pointing the same direction. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.

Behaviour On Record

What MTD's own history says about today's numbers

Realized volatility (21d)
32.9% 84th pct
Below its peak
-9.5%
vs 200-day average
+16.9%
Up days (1y)
49%

Mettler-Toledo International Inc. is currently running 32.9% annualised volatility over the last 21 sessions. Measured against MTD's own 13 years of daily returns rather than a market-wide average, that is the 84th percentile — elevated for this stock, against a typical reading of 23.6%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

MTD is trading -9.5% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -24.2%, and the deepest was -39.8% in 2023. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +16.9% from its 200-day moving average. Against every other day in its history, that gap ranks at the 81st percentile — a wider gap than this stock usually carries. Over the past year MTD closed higher on 49% of sessions, and it is currently 2 sessions into a rising streak.

On October specifically: over 13 years of records, MTD finished the month higher 9 of 13 times, with a median return of +2.8% and an average of +1.5%. Its strongest month historically has been November at +5.5% on average, its weakest February at -1.5%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: MTD has opened more than 2% away from the prior close in 118 of 3,267 sessions (3.6% of the time), with the largest gaps running +9.2% and -10.3%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, MTD moved an average of 4.7% in the session after earnings, closing higher 0 of those 3 times, with a median move of -0.7% and a largest of -13.3%.

All figures computed from 3,268 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against MTD's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of MTD's sector?

Mettler-Toledo International Inc. sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (lagging).

Sector rank
#3 of 12
Sector state
Lagging
Sector rotation score
36

Options Market

What is the options market pricing for MTD?

CallsPuts

For Mettler-Toledo International Inc.'s nearest expiry (2026-10-16, 9 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.19), with at-the-money implied volatility around 0.8%. The options market is pricing roughly a ±29.6% move by that expiry — a range of about $1081.56–$1993.12.

Put/call ratio (2026-10-16)
0.19
ATM implied volatility
0.8%
Total open interest
19
Expected move by 2026-10-16
±29.6% ($1081.56–$1993.12)

Analyst Rating Changes

Are analysts turning bullish or bearish on MTD?

Rothschild & Co most recently initiated coverage on Mettler-Toledo International Inc. to Sell on Sep 2, 2026 with a price target of $1200. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Rothschild & Co — Sell
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Sep 2, 2026Rothschild & CoInitiatedSell$1200
Sep 1, 2026RBC CapitalInitiatedSector Perform$1515
Aug 4, 2026Morgan StanleyMaintainedEqual-Weight$1275 → $1450
Aug 3, 2026Evercore ISI GroupMaintainedOutperform$1350 → $1500
Aug 3, 2026Wells FargoMaintainedEqual-Weight$1225 → $1450
Aug 3, 2026BarclaysMaintainedOverweight$1300 → $1575
Aug 3, 2026StifelMaintainedBuy$1400 → $1600
Jul 31, 2026JefferiesMaintainedBuy$1400 → $1580
Jul 6, 2026Evercore ISI GroupMaintainedOutperform$1300 → $1350
May 18, 2026StifelMaintainedBuy$1600 → $1400
May 12, 2026Morgan StanleyMaintainedEqual-Weight$1475 → $1275
May 11, 2026JP MorganMaintainedNeutral$1413 → $1200

MTD Competitive Positioning

Mettler-Toledo International Inc. (MTD) is tracked alongside these names in Diagnostics & Research on DailyIQ — ranked by market cap, with today's move alongside.

News Sentiment Analysis

Sentiment gathered from recent headlines

58/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Barclays lifted its price target for Mettler‑Toledo International to $1,700 from $1,575 while keeping an overweight recommendation. The upgrade reflects confidence in the company’s earnings outlook and product pipeline. The new target represents a modest upside relative to the current market price, suggesting a positive view of MTD’s near‑term prospects.
What did this article say?
Mettler‑Toledo International reported robust operating margins exceeding 29%, underscoring its status as a high‑quality, mission‑critical medtech equipment provider. Analysts highlighted the company’s strong profitability and stable business model, recommending a hold rating for investors. The commentary emphasized that while the valuation appears high, the firm’s consistent performance justifies a cautious yet supportive stance. No immediate catalysts or earnings surprises were noted, suggesting a steady outlook for the near term.
What did this article say?
Mettler‑Toledo International (MTD) attracted renewed investor interest after a spotlight on its precision instruments and diversified end markets, including pharmaceuticals and food manufacturing. The company’s share price rose 20.08% over the past 90 days and 8.08% in the last month, reflecting growing confidence. One‑year and three‑year total shareholder returns of 25.51% and 36.42% respectively suggest sustained momentum rather than a short‑term spike. The positive market reception indicates a material upside for MTD, though no single transformative event was cited.
What did this article say?
Goldman Sachs has increased its price target for Mettler‑Toledo International (MTD) to $1,510 from $1,440, reflecting a modest upside expectation. The firm maintains a neutral rating, indicating that the target lift is viewed as a slight improvement rather than a fundamental shift. The adjustment suggests confidence in MTD’s earnings trajectory but does not signal a major catalyst or strategic change.
What did this article say?
Mettler‑Toledo International (MTD) has delivered an average annual return of 16.64% over the past two decades, outperforming the broader market by 7.54% on an annualized basis. The data highlights the company’s strong historical performance and robust valuation relative to peers. While the figure underscores MTD’s long‑term track record, it does not signal any immediate change in guidance or operational outlook.
What did this article say?
Weitz Investment Management’s Q2 2026 investor letter lists Mettler‑Toledo International (MTD) among its top holdings, noting the company’s role in precision instruments across global markets. The letter provides no new financial guidance or earnings data for MTD, merely acknowledging its inclusion in the fund’s portfolio. The mention underscores MTD’s perceived stability but offers no actionable insight into its near‑term performance.
What did this article say?
Mettler‑Toledo International Inc. (MTD) has recently posted a 52‑week high of $152.5 on November 25, 2025, but has since slipped 15.1% from that peak. Over the past three months the stock has risen 14.4%, outperforming the Nasdaq Composite’s 2% gain. The company’s large‑cap status and diversified global operations underpin its resilience, yet the recent pullback suggests a potential short‑term correction.
What did this article say?
The article examines the Q2 earnings season for research tools and consumables, highlighting Mettler‑Toledo (MTD) among its peers. It outlines sector strengths such as recurring revenue from repeat purchases and customer loyalty, while noting challenges like high R&D costs and pricing pressure. MTD’s specific results are not detailed, but the piece suggests the industry may benefit from growing demand in emerging fields such as synthetic biology and personalized medicine.
What did this article say?
Mettler‑Toledo International (MTD) demonstrates solid financial health with a 66.7% ROIC and robust cash conversion, indicating efficient use of capital. The company maintains low debt relative to free cash flow, supporting a durable growth trajectory. However, the current valuation remains on the higher side, tempering the upside potential for investors. This combination suggests a cautiously optimistic outlook, with value considerations moderating the enthusiasm.
What did this article say?
UBS downgraded Mettler‑Toledo International (MTD) from buy to neutral and lowered its price target from $1,650 to $1,460, prompting a 2.2% decline in shares on Wednesday. The downgrade reflects concerns over the company’s earnings outlook and competitive positioning. The trade volume exceeded the daily average, indicating active market reaction. This downgrade is a confirmed negative catalyst that may influence future valuation and investor sentiment.

Technical Analysis

Real-time indicators across multiple timeframes

91
BULLISH
Technical indicators reflect the latest computed signal mix for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $11.85B combined position · 11 adding, 12 trimming, 2 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▼ Sell2,540,51112.63%$3.54B2026-01-29
BlackRock, Inc.▲ Buy1,882,3449.36%$2.40B2026-08-07
AllianceBernstein L.P.▼ Sell679,1013.38%$856.48M2026-08-14
Geode Capital Management, LLC▲ Buy612,1533.04%$780.46M2026-08-12
Morgan Stanley▼ Sell465,2262.31%$594.34M2026-08-13
Wellington Management Group LLP▲ Buy459,0642.28%$586.46M2026-08-14
Norges Bank▲ Buy399,5391.99%$510.42M2026-08-12
Goldman Sachs Group Inc▼ Sell252,1371.25%$322.11M2026-08-14
Invesco Ltd.▼ Sell241,8261.20%$308.94M2026-08-14
Northern Trust Corp▼ Sell223,1131.11%$285.03M2026-08-13
JPMorgan Chase & Co▼ Sell223,7311.11%$281.64M2026-08-12
Bank of America Corp▼ Sell188,5050.94%$240.82M2026-08-14
Point72 Asset Management, L.P.▲ Buy129,3870.64%$165.29M2026-08-14
AQR Capital Management LLC▲ Buy123,9720.62%$155.39M2026-08-14
Susquehanna International Group, LLP▲ Buy114,9040.57%$146.79M2026-08-14
Citigroup Inc▼ Sell90,7540.45%$115.94M2026-08-03
Marshall Wace, LLP▲ Buy76,9770.38%$98.34M2026-08-13
Loomis Sayles & Co L P▼ Sell74,5250.37%$95.21M2026-08-14
D. E. Shaw & Co., Inc.▼ Sell55,8410.28%$71.34M2026-08-14
Balyasny Asset Management L.P.▲ Buy54,6860.27%$69.86M2026-08-14
Citadel Advisors LLC• Hold42,5570.21%$54.37M2026-09-02
Millennium Management LLC▲ Buy42,0660.21%$53.74M2026-08-14
FMR LLC (Fidelity)▼ Sell35,0880.17%$44.82M2026-08-13
Wells Fargo & Company▲ Buy28,2840.14%$36.13M2026-08-14
Junto Capital Management LP• Hold24,5150.12%$28.80M2025-08-14
Q2 2026 flow:873.9K sh bought ($1.11B)393.9K sh sold ($501.84M)net +479.9K sh (+$612.97M)
Congressional Trading Activity
8 disclosed trades · ~$88.5K est. traded value · 4 buys, 4 sells
MemberChamberStateTypeAmountTradedFiled
Julia LetlowHouseLA05▼ Sell$1K - $15K2025-12-082026-01-13
Julia LetlowHouseLA05▲ Buy$1K - $15K2025-07-252026-01-13
Rob BresnahanHousePA08▲ Buy$1K - $15K2025-05-152025-05-31
Rob BresnahanHousePA08▼ Sell$1K - $15K2025-04-082025-04-28
Julie JohnsonHouseTX32▼ Sell$1K - $15K2025-04-012025-05-14
Tommy TubervilleSenateAL▼ Sell$1K - $15K2023-04-032023-05-12
Susan M. CollinsSenateME▲ Buy$1K - $15K2016-12-012017-05-10
Susan M. CollinsSenateME▲ Buy$15K - $50K2015-01-132015-01-29